Opigolix
Opigolix (ASP-1707) is a Gonadotropin-releasing hormone (GnRH) receptor antagonist, used for the research of endometriosis and rheumatoid arthritis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 912587-25-8
- Formel: C25H19F3N4O5S
- Molecular Weight:544.50
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
GnRH receptor[1]
In Vitro
Opigolix (Compound 726) is a GnRH receptor antagonist, used for the research of sex hormone-dependent diseases, particularly GnRH-related diseases[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 912587-25-8
-
Molecular Weight 544.50
-
Formel C25H19F3N4O5S
-
SMILES
O=C(C1=CC(S(NC([C@H](O)C)=N)(=O)=O)=C(F)C=C1)/C(C(C2=C(C=CC(F)=C2)F)=O)=C3NC4=CC=CC=C4N\3
-
Synonyms
ASP-1707
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)